Piperazine derivatives with central pharmacological activity used as therapeutic tools

被引:77
作者
Brito, Adriane F. [1 ]
Moreira, Lorrane K. S. [1 ]
Menegatti, Ricardo [2 ]
Costa, Elson A. [3 ]
机构
[1] Univ Fed Goias, ICB, Post Grad Program Biol Sci, Campus Samambaia, BR-74001970 Goiania, Go, Brazil
[2] Univ Fed Goias, Lab Med Pharmaceut Chem, Fac Pharm, Goiania, Go, Brazil
[3] Univ Fed Goias, ICB, Dept Pharmacol, Campus Samambaia 314, BR-74001970 Goiania, Go, Brazil
关键词
Antidepressant; Anxiolytic; Medicinal chemistry; Neuropharmacology; LASSBIO-579; DRUGS;
D O I
10.1111/fcp.12408
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Medicinal chemistry is a science applied to the search and discovery of new therapeutic agents for the treatment of various diseases. Therefore, promising structures have been identified; one of these structures is the piperazine moiety, a cyclic molecule containing two nitrogen atoms in positions 1 and 4 as well as four carbon atoms. Many piperazine derivatives have central pharmacological activity that mainly involves the activation of the monoamine pathway. Thus, piperazine derivatives have been the subject of research for many central therapeutic applications, including antipsychotic, antidepressant and anxiolytic applications. Benzylpiperazine is the prototype of piperazine derivatives; this substance is the main component of recreational drugs, partly due to its stimulant and euphoric effects. This paper describes some piperazine derivatives used therapeutically as antipsychotic (clozapine), antidepressant (vortioxetine) and anxiolytic (buspirone) drugs.
引用
收藏
页码:13 / 24
页数:12
相关论文
共 33 条
[1]  
[Anonymous], 2016, Anxiety disorders
[2]   Piperazine compounds as drugs of abuse [J].
Arbo, M. D. ;
Bastos, M. L. ;
Carmo, H. F. .
DRUG AND ALCOHOL DEPENDENCE, 2012, 122 (03) :174-185
[3]  
Asif M., 2015, INT J ADV SCI RES, V1, P5, DOI [10.7439/ijasr.v1i1.1766, DOI 10.7439/IJASR.V1I1.1766]
[4]   Xylopia aethiopica fruit extract exhibits antidepressant-like effect via interaction with serotonergic neurotransmission in mice [J].
Biney, Robert P. ;
Benneh, Charles K. ;
Ameyaw, Elvis O. ;
Boakye-Gyasi, Eric ;
Woode, Eric .
JOURNAL OF ETHNOPHARMACOLOGY, 2016, 184 :49-57
[5]  
BOCKAERT J, 1987, N-S ARCH PHARMACOL, V335, P588
[6]   A new piperazine derivative: 1-(4-(3,5-di-tert-butyl-4-hydroxybenzyl) piperazin-1-yl)-2-methoxyethan-1-one with antioxidant and central activity [J].
Brito, Adriane F. ;
Braga, Patricia C. C. S. ;
Moreira, Lorrane K. S. ;
Silva, Dayane M. ;
Silva, Daiany P. B. ;
Sanz, German ;
Vaz, Boniek G. ;
de Carvalho, Flavio S. ;
Liao, Luciano M. ;
Silva, Rafaela R. ;
Noel, Francois ;
Neri, Hiasmin F. S. ;
Ghedini, Paulo C. ;
de Carvalho, Murilo F. ;
Gil, Eric de S. ;
Costa, Elson A. ;
Menegatti, Ricardo .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 (03) :255-269
[7]   Anxiolytic-like effect of 2-(4-((1-phenyl-1H-pyrazol-4-yl)methyl)piperazin-1-yl)ethan-1-ol is mediated through the benzodiazepine and nicotinic pathways [J].
Brito, Adriane F. ;
Fajemiroye, James O. ;
Neri, Hiasmin F. S. ;
Silva, Dayane M. ;
Silva, Daiany P. B. ;
Sanz, German ;
Vaz, Boniek G. ;
de Carvalho, Flavio S. ;
Ghedini, Paulo C. ;
Liao, Luciano M. ;
Menegatti, Ricardo ;
Costa, Elson A. .
CHEMICAL BIOLOGY & DRUG DESIGN, 2017, 90 (03) :432-442
[8]   Central pharmacological activity of a new piperazine derivative: 4-(1-Phenyl-1h-pyrazol-4-ylmethyl)-piperazine-1-carboxylic acid ethyl ester [J].
de Brito, Adriane Ferreira ;
Rodrigues Martins, Jose Luis ;
Fajemiroye, James Oluwagbamigbe ;
Galdino, Pablinny Moreira ;
Monteiro De Lima, Thereza Christina ;
Menegatti, Ricardo ;
Costa, Elson Alves .
LIFE SCIENCES, 2012, 90 (23-24) :910-916
[9]   Privileged structures: Applications in drug discovery [J].
DeSimone, RW ;
Currie, KS ;
Mitchell, SA ;
Darrow, JW ;
Pippin, DA .
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2004, 7 (05) :473-493
[10]   Privileged structures: A useful concept for the rational design of new lead drug candidates [J].
Duarte, Carolina D. ;
Barreiro, Eliezer J. ;
Fraga, Carlos A. M. .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2007, 7 (11) :1108-1119